Featured Slider

First ever EAN Annual Report looks back on the European Academy of Neurology's initiatives, activities and achievements in 2025

Study analysing data of 38,816 study participants of the UK Biobank, an ongoing study investigating associations between sleep duration, a validated machine-learning-derived MRI signature of AD-related atrophy, and three cognitive test scores.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for August 2026.

New EAN President, Prof. Kailash Bhatia, discusses his priorities for the EAN, the role of AI in neurology, and more, in this EAN TV interview from the EAN Congress 2026

This month’s selected paper collected European-ancestry data from several large consortia and cohorts for a major consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for July 2026.

From award-winning discoveries to AI, biomarkers and precision medicine, this popular session captured the biggest ideas of the EAN Congress 2026 and looked ahead to Gothenburg 2027 under new EAN leadership.

The EAN Congress 2026 Presidential Symposium in Geneva offered a compelling snapshot of modern neurology in motion – a field increasingly defined by its ability to turn scientific discovery into tangible benefits for patients.

The EAN Congress 2026 opened with a clear message: the future of neurology will be shaped not by individual efforts alone, but by a community working together across borders, disciplines and generations.

The EAN 2026 Opening Session took place in the Main Auditorium of the Palexpo, Geneva, on Saturday night, with the whole show streamed live on the EAN Congress website.

EAN Programme Committee Chair, Irena Rektorová, & EAN President, Elena Moro preview some major highlights of the EAN Congress 2026, taking place in Geneva in just a few weeks.

Welcome to the June 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions

Results from the TRIDENT trial, testing a daily pill combining three low-dose blood-pressure medicines for people who have had an intracerebral haemorrhage.

Scientific Committee Chair, Gereon R. Fink provides news on the EAN Scientific Panels, guideline activity and several ongoing and ending projects.

Welcome to the May 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!